Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-08 | New | $215,000 | $215,000 | Other | 06c | SEC link |
| 2025-05-07 | New | $0 | $0 | Equity Only | 06c | SEC link |
| 2022-07-12 | New | $45,400 | $45,400 | Equity Only | 06b | SEC link |
| 2018-06-08 | Amended | $0 | $0 | Equity Only | 06c | SEC link |
| 2018-06-06 | Amended | Yet to Sell | $0 | Equity Only | 06c | SEC link |
| 2018-03-30 | Amended | Yet to Sell | $0 | Equity Only | 06c | SEC link |
| 2017-02-02 | New | Yet to Sell | $0 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Mike Black | Executive |
| Jim La Bate | Director |
| Rick Rotondo | Executive |
| Peter Travers | Director, Executive, Promoter |
| Ken Watkins | Executive |
| Yung Ping Yeh | Director |